Stay updated on Pembrolizumab in Recurrent PCNSL Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Recurrent PCNSL Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New entries identify the investigator and sponsoring institution (Prof. Dr. Matthias Preusser; Medical University of Vienna) and add user-focused navigation items (How to Read a Study Record, Common Questions, How to Join a Study). Additionally, the page labels are updated (Intervention/Treatment) and a new revision tag (Revision: v3.6.0) is introduced.
    Difference
    2%
    Check dated 2026-06-13T00:31:24.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page now shows revision v3.5.5, replacing the previous v3.5.4. This update reflects a new page/template version rather than changes to substantive content.
    Difference
    0.1%
    Check dated 2026-06-05T21:35:05.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.5.4 replaces the prior v3.5.3, signaling a small metadata update. This change does not modify any study details, eligibility criteria, or results on the page.
    Difference
    0.1%
    Check dated 2026-05-15T15:39:49.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page’s displayed revision/version number was updated from v3.5.2 to v3.5.3, reflecting a website release rather than a change to the underlying study information.
    Difference
    0.1%
    Check dated 2026-04-24T06:30:42.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2 and removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:52:23.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added revision note: v3.5.0. Removed revision note: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T05:30:54.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Recurrent PCNSL Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Recurrent PCNSL Clinical Trial page.